La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Gerresheimer Résultats passés
Passé contrôle des critères 5/6
Gerresheimer has been growing earnings at an average annual rate of 4.5%, while the Life Sciences industry saw earnings growing at 16.5% annually. Revenues have been growing at an average rate of 9.3% per year. Gerresheimer's return on equity is 7.8%, and it has net margins of 5.8%.
Informations clés
4.5%
Taux de croissance des bénéfices
3.1%
Taux de croissance du BPA
Life Sciences Croissance de l'industrie | 26.8% |
Taux de croissance des recettes | 9.3% |
Rendement des fonds propres | 7.8% |
Marge nette | 5.8% |
Prochaine mise à jour des résultats | 10 Oct 2024 |
Mises à jour récentes des performances passées
Recent updates
Shareholders Will Most Likely Find Gerresheimer AG's (ETR:GXI) CEO Compensation Acceptable
May 30Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion
May 22An Intrinsic Calculation For Gerresheimer AG (ETR:GXI) Suggests It's 40% Undervalued
May 03Analysts Are Updating Their Gerresheimer AG (ETR:GXI) Estimates After Its First-Quarter Results
Apr 14Gerresheimer's (ETR:GXI) Dividend Will Be €1.25
Apr 12Gerresheimer (ETR:GXI) Has A Somewhat Strained Balance Sheet
Apr 10Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25
Feb 25Investors Still Waiting For A Pull Back In Gerresheimer AG (ETR:GXI)
Feb 10At €92.85, Is Gerresheimer AG (ETR:GXI) Worth Looking At Closely?
Jan 23Are Investors Undervaluing Gerresheimer AG (ETR:GXI) By 28%?
Jan 03Is Gerresheimer (ETR:GXI) Using Too Much Debt?
Dec 15When Should You Buy Gerresheimer AG (ETR:GXI)?
Oct 19An Intrinsic Calculation For Gerresheimer AG (ETR:GXI) Suggests It's 42% Undervalued
Oct 01Is Gerresheimer (ETR:GXI) Using Too Much Debt?
Aug 26Should You Investigate Gerresheimer AG (ETR:GXI) At €105?
Jul 06Gerresheimer AG's (ETR:GXI) Intrinsic Value Is Potentially 94% Above Its Share Price
Jun 18Gerresheimer (ETR:GXI) Is Paying Out A Dividend Of €1.25
Apr 05Is Gerresheimer (ETR:GXI) A Risky Investment?
Mar 17Gerresheimer's (ETR:GXI) Dividend Will Be €1.25
Feb 27What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?
Feb 15Is Gerresheimer (ETR:GXI) Using Too Much Debt?
Nov 18Is Now An Opportune Moment To Examine Gerresheimer AG (ETR:GXI)?
Sep 06Is Gerresheimer (ETR:GXI) A Risky Investment?
Aug 18Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25
May 31Gerresheimer (ETR:GXI) Will Pay A Dividend Of €1.25
May 16Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25
May 02Gerresheimer (ETR:GXI) Has Affirmed Its Dividend Of €1.25
Apr 18Gerresheimer (ETR:GXI) Has Affirmed Its Dividend Of €1.25
Apr 04Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25
Mar 21Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25
Mar 06Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25
Feb 20At €72.85, Is Gerresheimer AG (ETR:GXI) Worth Looking At Closely?
Feb 17Is Gerresheimer (ETR:GXI) A Risky Investment?
Jan 06What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?
Nov 04Does Gerresheimer (ETR:GXI) Have A Healthy Balance Sheet?
Sep 23Is Gerresheimer AG (ETR:GXI) Trading At A 24% Discount?
Sep 05Should You Think About Buying Gerresheimer AG (ETR:GXI) Now?
Jul 11Is Gerresheimer (ETR:GXI) A Risky Investment?
Jun 24A Look At The Intrinsic Value Of Gerresheimer AG (ETR:GXI)
May 03What Is Gerresheimer AG's (ETR:GXI) Share Price Doing?
Mar 29Is Gerresheimer AG's (ETR:GXI) 1.5% Dividend Worth Your Time?
Mar 16Read This Before Judging Gerresheimer AG's (ETR:GXI) ROE
Mar 03Ventilation des recettes et des dépenses
Comment Gerresheimer gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
31 May 24 | 2,002 | 115 | 368 | 15 |
29 Feb 24 | 1,999 | 117 | 372 | 13 |
30 Nov 23 | 1,990 | 116 | 373 | 16 |
31 Aug 23 | 1,974 | 107 | 380 | 19 |
31 May 23 | 1,959 | 107 | 378 | 23 |
28 Feb 23 | 1,904 | 97 | 368 | 26 |
30 Nov 22 | 1,817 | 96 | 351 | 22 |
31 Aug 22 | 1,725 | 91 | 336 | 17 |
31 May 22 | 1,634 | 82 | 314 | 15 |
28 Feb 22 | 1,566 | 85 | 298 | 12 |
30 Nov 21 | 1,498 | 84 | 285 | 10 |
31 Aug 21 | 1,465 | 86 | 278 | 8 |
31 May 21 | 1,432 | 93 | 272 | 8 |
28 Feb 21 | 1,418 | 94 | 272 | 9 |
30 Nov 20 | 1,419 | 89 | 275 | 8 |
31 Aug 20 | 1,385 | -25 | 275 | 7 |
31 May 20 | 1,394 | -32 | 275 | 5 |
29 Feb 20 | 1,388 | -14 | 273 | 1 |
30 Nov 19 | 1,392 | 81 | 273 | 0 |
31 Aug 19 | 1,415 | 207 | 273 | 0 |
31 May 19 | 1,410 | 207 | 270 | 0 |
28 Feb 19 | 1,386 | 179 | 265 | 0 |
30 Nov 18 | 1,368 | 129 | 259 | 0 |
31 Aug 18 | 1,351 | 124 | 258 | 0 |
31 May 18 | 1,329 | 131 | 256 | 0 |
28 Feb 18 | 1,336 | 137 | 258 | 0 |
30 Nov 17 | 1,348 | 101 | 259 | 0 |
31 Aug 17 | 1,331 | 49 | 257 | 0 |
31 May 17 | 1,350 | 53 | 259 | 0 |
28 Feb 17 | 1,358 | 56 | 258 | 0 |
30 Nov 16 | 1,375 | 58 | 259 | 0 |
31 Aug 16 | 1,299 | 118 | 243 | 0 |
31 May 16 | 1,292 | 106 | 240 | 0 |
29 Feb 16 | 1,301 | 99 | 238 | 0 |
30 Nov 15 | 1,283 | 96 | 231 | 0 |
31 Aug 15 | 1,335 | 69 | 236 | 0 |
31 May 15 | 1,315 | 69 | 235 | 0 |
28 Feb 15 | 1,294 | 68 | 230 | 0 |
30 Nov 14 | 1,290 | 66 | 228 | 0 |
31 Aug 14 | 1,282 | 71 | 235 | 0 |
31 May 14 | 1,275 | 71 | 231 | 0 |
28 Feb 14 | 1,267 | 63 | 235 | 0 |
30 Nov 13 | 1,266 | 62 | 237 | 0 |
31 Aug 13 | 1,266 | 64 | 233 | 0 |
Des revenus de qualité: GXI has high quality earnings.
Augmentation de la marge bénéficiaire: GXI's current net profit margins (5.8%) are higher than last year (5.4%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: GXI's earnings have grown by 4.5% per year over the past 5 years.
Accélération de la croissance: GXI's earnings growth over the past year (7.9%) exceeds its 5-year average (4.5% per year).
Bénéfices par rapport au secteur d'activité: GXI earnings growth over the past year (7.9%) exceeded the Life Sciences industry -13%.
Rendement des fonds propres
ROE élevé: GXI's Return on Equity (7.8%) is considered low.